3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
5
Active not recruiting
3
Withdrawn
1
Terminated
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Breast Neoplasms
4
Neoplasm Metastasis
3
Multiple Myeloma
3
Melanoma
3
Carcinoma, Intraductal, Noninfiltrating
3
Brain Neoplasms
3
Urinary Bladder Neoplasms
2
Thrombocytosis
2
Stomach Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hematologic Neoplasms
2
Gastrointestinal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Sarcoma, Kaposi
1
Sarcoma
1
Rhabdomyosarcoma
1
Resectable Pancreatic Carcinoma
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmacytoma
1
Interventions
Capecitabine
35
Oxaliplatin
32
Fluorouracil
29
Leucovorin
26
Irinotecan
22
Bevacizumab
19
Cetuximab
17
Radiotherapy
16
Radiation
11
Surgical Procedures, Operative
6
Radiotherapy, Intensity-Modulated
5
Gene Expression Profiling
5
Chemotherapy, Adjuvant
5
Celecoxib
5
Neoadjuvant Therapy
4
Immunohistochemistry
4
Biopsy
4
Amplified Fragment Length Polymorphism Analysis
4
cediranib
3
Reverse Transcriptase Polymerase Chain Reaction
3
Receptor Protein-Tyrosine Kinases
3
Folfox protocol
3
Drug Therapy
3
Cisplatin
3
sargramostim
2
regorafenib
2
pembrolizumab
2
fludarabine phosphate
2
aldesleukin
2
Surveys and Questionnaires
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Rectal Neoplasms
×
Specimen Handling
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled